Eliana Clark, EVP, Chief Technical Officer at Intellia Therapeutics, Inc. (NTLA), sold 679 shares at $8.99 ($6K) on 2025-03-04, disclosed to the SEC on 2025-03-04.
Seasonal sale ($6k) by EVP, Chief Technical Officer — this insider has traded NTLA in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| NTLA | SELL | 2025-07-03 | $10K | — | Filing → |
| NTLA | SELL | 2025-01-06 | $187K | — | Filing → |
| NTLA | SELL | 2024-07-03 | $9K | — | Filing → |